Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (3905)	3/6/1998 9:49:00 PM
From: billkirn	Read Replies (1) \| Respond to of 6136

Steve: We have some serious good news coming in the next few months so I would expect AGPH to move upward for some time, although within the established channel. I was shocked to see the insider selling by the key people at Agouron and was beginning to think they knew something we should know. Well, they did, and they took action for the short term. I am somewhat shaken that the management still thinks the $300 price in 3 years is possible since they sold at $52 but I would probably do the same with a portion of my interest in that situation. Lets hope ag3340 is great and the Rhinovirus protease inhibitor tops expectations. If so we will all be winners in a very big way. Bill